Format
Sort by
Items per page

Send to

Choose Destination

Best matches for metaxalone:

Postmortem Metaxalone (Skelaxin®) Data from North Carolina. Bishop-Freeman SC et al. J Anal Toxicol. (2015)

Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model. Vuletić L et al. Pharm Res. (2018)

Metaxalone estimation in biological matrix using high-throughput LC-MS/MS bioanalytical method. Goswami D et al. J Chromatogr B Analyt Technol Biomed Life Sci. (2012)

Search results

Items: 1 to 20 of 43

1.

A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain.

Friedman BW, Irizarry E, Solorzano C, Zias E, Pearlman S, Wollowitz A, Jones MP, Shah PD, Gallagher EJ.

Ann Emerg Med. 2019 Apr 5. pii: S0196-0644(19)30139-8. doi: 10.1016/j.annemergmed.2019.02.017. [Epub ahead of print]

PMID:
30955985
2.

Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.

Vuletić L, Khan MZI, Špoljarić D, Radić M, Cetina-Čižmek B, Filipović-Grčić J.

Pharm Res. 2018 Jun 22;35(8):163. doi: 10.1007/s11095-018-2434-1.

PMID:
29934663
3.

Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants.

Moody DE, Fu Y, Fang WB.

Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):327-334. doi: 10.1111/bcpt.12999. Epub 2018 Apr 19.

PMID:
29504673
4.

Simultaneous screening and detection of pharmaceutical co-crystals by the one-step DSC-FTIR microspectroscopic technique.

Lin SY.

Drug Discov Today. 2017 Apr;22(4):718-728. doi: 10.1016/j.drudis.2016.12.001. Epub 2016 Dec 12. Review.

PMID:
27979712
5.

Postmortem Metaxalone (Skelaxin®) Data from North Carolina.

Bishop-Freeman SC, Miller A, Hensel EM, Winecker RE.

J Anal Toxicol. 2015 Oct;39(8):629-36. doi: 10.1093/jat/bkv066.

PMID:
26378137
6.

Serotonin syndrome associated with therapeutic metaxalone in a patient with cirrhosis.

Surmaitis RM, Nappe TM, Cook MD.

Am J Emerg Med. 2016 Feb;34(2):346.e5-6. doi: 10.1016/j.ajem.2015.06.043. Epub 2015 Jun 19. No abstract available.

PMID:
26159819
7.

A rare fatality attributed solely to metaxalone.

Curtis B, Jenkins C, Wiens AL.

J Anal Toxicol. 2015 May;39(4):321-3. doi: 10.1093/jat/bkv008. Epub 2015 Feb 10.

PMID:
25673649
8.

Serotonin syndrome following metaxalone overdose and therapeutic use of a selective serotonin reuptake inhibitor.

Martini DI, Nacca N, Haswell D, Cobb T, Hodgman M.

Clin Toxicol (Phila). 2015 Mar;53(3):185-7. doi: 10.3109/15563650.2015.1009993. Epub 2015 Feb 11.

PMID:
25671244
9.

Serotonin syndrome associated with metaxalone overdose.

Bosak AR, Skolnik AB.

J Med Toxicol. 2014 Dec;10(4):402-5. doi: 10.1007/s13181-014-0404-5.

10.

Development and validation of a stability-indicating assay including the isolation and characterization of degradation products of metaxalone by LC-MS.

Rao RN, Farah H, Sahu PK, Janarthan M, Naidu ChG.

Biomed Chromatogr. 2013 Dec;27(12):1733-40. doi: 10.1002/bmc.2987. Epub 2013 Jul 23.

PMID:
23881540
11.

Kinetics study of metaxalone degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC method.

Marothu VK, Dash RN, Vemula S, Donkena S, Devi R, Gorrepati M.

J Pharm Anal. 2012 Dec;2(6):431-436. doi: 10.1016/j.jpha.2012.08.004. Epub 2012 Sep 14.

12.

Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form.

Trivedi RK, Patel MC.

Sci Pharm. 2012 Apr-Jun;80(2):353-66. doi: 10.3797/scipharm.1112-08. Epub 2012 Feb 21.

13.

Metaxalone estimation in biological matrix using high-throughput LC-MS/MS bioanalytical method.

Goswami D, Saha A, Gurule S, Khuroo A, Monif T, Vats P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:132-6. doi: 10.1016/j.jchromb.2012.05.034. Epub 2012 Jun 4.

PMID:
22766230
14.

New Stability-Indicating RP-HPLC Method for Determination of Diclofenac Potassium and Metaxalone from their Combined Dosage Form.

Panda SS, Patanaik D, Ravi Kumar BV.

Sci Pharm. 2012 Jan-Mar;80(1):127-37. doi: 10.3797/scipharm.1109-16. Epub 2011 Dec 5.

15.

Muscle relaxants for pain management in rheumatoid arthritis.

Richards BL, Whittle SL, Buchbinder R.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008922. doi: 10.1002/14651858.CD008922.pub2. Review.

PMID:
22258993
16.

Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents.

Phillips PJ, Smith SG, Kolpin DW, Zaugg SD, Buxton HT, Furlong ET, Esposito K, Stinson B.

Environ Sci Technol. 2010 Jul 1;44(13):4910-6. doi: 10.1021/es100356f.

17.

Pediatric metaxalone ingestions reported to Texas poison control centers, 2000-2007.

Forrester MB.

Pediatr Emerg Care. 2010 Jan;26(1):15-8. doi: 10.1097/PEC.0b013e3181c330dc.

PMID:
20042913
18.

Adult metaxalone ingestions reported to Texas poison control centers, 2000-2006.

Forrester MB.

Hum Exp Toxicol. 2010 Jan;29(1):55-62. doi: 10.1177/0960327108098150. Epub 2009 Nov 19.

PMID:
19933254
19.

Choosing a skeletal muscle relaxant.

See S, Ginzburg R.

Am Fam Physician. 2008 Aug 1;78(3):365-70. Review.

20.

HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma.

Mistri HN, Jangid AG, Pudage A, Shrivastav P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 15;864(1-2):137-48. doi: 10.1016/j.jchromb.2008.02.004. Epub 2008 Feb 17.

PMID:
18313371

Supplemental Content

Loading ...
Support Center